Psyence Biomedical Ltd. (PBM)
USD 1.53
(-12.57%)
USD 1.53
(-12.57%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Assets | 1.13 Million | 258.93 Million | 256.22 Million | 4.9 Million |
| Total Current Assets | 1.12 Million | 1.2 Million | 973.22 Thousand | 4.9 Million |
| Cash And Short Term Investments | 762.79 Thousand | 128.67 Thousand | 648.28 Thousand | 4.75 Million |
| Cash and Cash Equivalents | 762.79 Thousand | 128.67 Thousand | 648.28 Thousand | 4.75 Million |
| Short Term Investments | - | - | - | - |
| Net Receivables | 41.74 Thousand | 828.81 Thousand | 39.54 Thousand | 138.06 Thousand |
| Inventory | - | 1.00 | -39.54 Thousand | - |
| Other Current Assets | 322.12 Thousand | 248.22 Thousand | 324.93 Thousand | - |
| Total Non-Current Assets | 5487.00 | 257.72 Million | 255.25 Million | - |
| Net PPE | 5487.00 | - | - | - |
| Good Will And Intangible Assets | - | - | - | - |
| Good Will | - | - | - | - |
| Intangible Assets | - | - | - | - |
| Long-Term Investments | - | 257.72 Million | 255 Million | - |
| Tax Assets | - | - | - | - |
| Other Non Current Assets | - | -1.00 | 248.64 Thousand | - |
| Other Assets | - | - | - | - |
| Total Liabilities | 12.1 Million | 14.27 Million | 19.57 Million | 101.07 Thousand |
| Total Current Liabilities | 12.1 Million | 14.27 Million | 68.7 Thousand | 101.07 Thousand |
| Account Payables | 562.35 Thousand | 1.62 Million | 36.88 Thousand | 13.44 Thousand |
| Tax Payables | - | - | - | - |
| Short Term Debt | 7.65 Million | - | - | - |
| Deferred Revenue | -562.35 Thousand | - | - | - |
| Other Current Liabilities | 4.44 Million | 12.64 Million | 31.81 Thousand | 87.63 Thousand |
| Total Non Current Liabilities | - | - | 19.51 Million | - |
| Long-Term Debt | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - |
| Other Non Current Liabilities | - | - | 19.51 Million | - |
| Other Liabilities | - | - | - | - |
| Total Equity | -10.97 Million | 244.65 Million | 236.64 Million | 4.8 Million |
| Stock Holders Equity | -10.97 Million | 244.65 Million | 236.64 Million | 4.8 Million |
| Common Stock | 46.12 Million | 258.55 Million | 255 Million | - |
| Retained Earnings | -57.45 Million | -13.89 Million | -18.35 Million | - |
| Accumulated other comprehensive income | 361.05 Thousand | - | - | - |
| Common Stock Equity | -10.97 Million | 244.65 Million | 236.64 Million | 4.8 Million |
| Capital Lease Obligation | - | - | - | - |
| Total Investments | - | 257.72 Million | 255 Million | - |
| Total Debt | 7.65 Million | - | - | - |
| Net Debt | 6.89 Million | -128.67 Thousand | -648.28 Thousand | -4.75 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Total Assets | 1.13 Million | 1132.16 | 12.68 Million | 16.72 Million | 16.4 Million | 258.93 Million |
| Total Current Assets | 1.12 Million | 1126.67 | 162.51 Thousand | 181.39 Thousand | 288.59 Thousand | 1.2 Million |
| Cash And Short Term Investments | 762.79 Thousand | 733.19 | 88.17 Thousand | 9802.00 | 15.95 Thousand | 128.67 Thousand |
| Cash and Cash Equivalents | 762.79 Thousand | 733.19 | 88.17 Thousand | 9802.00 | 15.95 Thousand | 128.67 Thousand |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | 41.74 Thousand | - | 53.65 Thousand | 67.18 Thousand | 60.89 Thousand | 828.81 Thousand |
| Inventory | - | - | - | - | 1.00 | 1.00 |
| Other Current Assets | 322.12 Thousand | 71.36 | 20.68 Thousand | 104.41 Thousand | 211.74 Thousand | 248.22 Thousand |
| Total Non-Current Assets | 5487.00 | 5.49 | 12.51 Million | 16.54 Million | 16.11 Million | 257.72 Million |
| Net PPE | 5487.00 | 5.49 | - | - | - | - |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | - | 12.51 Million | 16.54 Million | 16.11 Million | 257.72 Million |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | - | - | - | - | - | -1.00 |
| Other Assets | - | - | - | - | - | - |
| Total Liabilities | 12.1 Million | 12.1 Thousand | 16.17 Million | 15.26 Million | 14.87 Million | 14.27 Million |
| Total Current Liabilities | 12.1 Million | 12.1 Thousand | 16.17 Million | 15.26 Million | 14.87 Million | 14.27 Million |
| Account Payables | 562.35 Thousand | 562.35 | - | - | - | - |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | 7.65 Million | 10.44 Thousand | 1.6 Million | 1.17 Million | 685 Thousand | - |
| Deferred Revenue | -562.35 Thousand | 126.14 | - | - | - | - |
| Other Current Liabilities | 4.44 Million | 968.51 | 14.56 Million | 14.08 Million | 14.19 Million | 14.27 Million |
| Total Non Current Liabilities | - | - | - | - | - | - |
| Long-Term Debt | - | - | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - | - | - |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | -10.97 Million | -10.97 Thousand | -3.49 Million | 1.46 Million | 1.52 Million | 244.65 Million |
| Stock Holders Equity | -10.97 Million | -10.97 Thousand | -3.49 Million | 1.46 Million | 1.52 Million | 244.65 Million |
| Common Stock | 46.12 Million | 46.12 Thousand | 12.57 Million | 16.61 Million | 16.17 Million | 258.55 Million |
| Retained Earnings | -57.45 Million | -57.45 Thousand | -16.06 Million | -15.15 Million | -14.65 Million | -13.89 Million |
| Accumulated other comprehensive income | 361.05 Thousand | 361.06 | - | - | - | - |
| Common Stock Equity | -10.97 Million | -10.97 Thousand | -3.49 Million | 1.46 Million | 1.52 Million | 244.65 Million |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | - | - | 12.51 Million | 16.54 Million | 16.11 Million | 257.72 Million |
| Total Debt | 7.65 Million | 10.44 Thousand | 1.6 Million | 1.17 Million | 685 Thousand | - |
| Net Debt | 6.89 Million | 9713.81 | 1.51 Million | 1.16 Million | 669.04 Thousand | -128.67 Thousand |
SPIC
206560
ROS
ALNY
ESR
603118